SLC38A11 may influence the overall energy and metabolic environment of immune cells, indirectly impacting the activation and regulation of STAT3 and CREB1, thereby contributing to the pathogenic IR in MS. This evidence concerns the gene SLC38A11 and myeloid sarcoma.